Acetazolamide-responsive Myotonia
Description
Acetazolamide-responsive myotonia is a form of potassium-aggravated myotonia (PAM, see this term) which shows dramatic improvement with the use of acetazolamide (ACZ).
Clinical Features
Top most frequent phenotypes and symptoms related to Acetazolamide-responsive Myotonia
- Gait disturbance
- Dysphagia
- Hypertonia
- Hypothyroidism
- Myalgia
- Ophthalmoplegia
- Muscle cramps
- Chest pain
- EMG abnormality
- Myotonia
And another 2 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Acetazolamide-responsive Myotonia Is also known as painful myotonia, acetazolamide-responsive congenital myotonia, acz-responsive congenital myotonia, painful congenital myotonia, myotonia-painful contractions syndrome, acz-responsive myotonia.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Acetazolamide-responsive Myotonia Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
SCN4A (Myotonia) DNA Sequencing Test.
By Athena Diagnostics Inc (United States).
SCN4A
Specificity
100 %
Genes
100 % |
Early Onset Myotonia Evaluation.
By Athena Diagnostics Inc (United States).
SCN4A, CLCN1, DMPK
Specificity
34 %
Genes
100 % |
Myotonic Syndrome Advanced Evaluation.
By Athena Diagnostics Inc (United States).
SCN4A, CNBP, CAV3, CLCN1, DMPK, HSPG2, ATP2A1
Specificity
15 %
Genes
100 % |
Periodic Paralysis Advanced Sequencing Evaluation.
By Athena Diagnostics Inc (United States).
SCN4A, CACNA1S, KCNJ2
Specificity
34 %
Genes
100 % |
Congenital Myasthenic Syndrome Advanced Sequencing Evaluation.
By Athena Diagnostics Inc (United States).
SCN4A, CHAT, CHRNA1, CHRNB1, CHRND, CHRNE, COLQ, DOK7, DPAGT1, AGRN, GFPT1, MUSK, RAPSN
Specificity
8 %
Genes
100 % |
Neuromuscular Disorders Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
RYR1, BIN1, SCN4A, SGCA, SGCB, SGCD, SGCE, SGCG, SLC25A4, SUCLA2, SUCLG1, TWNK, TCAP, TIA1, TK2, TNNI2, TNNT1, TPM2, TPM3, MYOT , (...)
View the complete list with 124 more genes
Specificity
1 %
Genes
100 % |
NGS Rhabdomyolysis and Metabolic Myopathies Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
RYR1, SCN4A, SLC16A1, SUCLA2, TWNK, TK2, TSFM, LPIN1, SLC25A20, CASQ1, CAV3, RRM2B, FKRP, CPT2, SIL1, CTDP1, ANO5, TSEN54, DGUOK, DMD , (...)
View the complete list with 27 more genes
Specificity
3 %
Genes
100 % |
NGS Rhabdomyolysis and Metabolic Myopathies Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
RYR1, SCN4A, SLC16A1, SUCLA2, TWNK, TK2, TSFM, LPIN1, SLC25A20, CASQ1, CAV3, RRM2B, FKRP, CPT2, SIL1, CTDP1, ANO5, TSEN54, DGUOK, DMD , (...)
View the complete list with 27 more genes
Specificity
3 %
Genes
100 % |
You can get up to 120 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like PARIETAL FORAMINA 2; PFM2 THANATOPHORIC DYSPLASIA, TYPE II; TD2 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3 CATARACT 12, MULTIPLE TYPES; CTRCT12 CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME